港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

九源基因

6.090

+0.000

成交量：5.54萬

成交額：33.71萬

市值：14.92億

市盈率：8.35

高：6.100

開：6.090

低：6.040

收：6.090

資料載入中...

總覽公司新聞資訊公告

九源基因：2024年腫瘤產品佔營收19.47%，血液產品佔9.96%

【九源基因(02566.HK)將於7月30日派發末期股息每10股0.56元】九源基因(02566.HK)發佈公告，該公司將於2025年7月30日派發末期股息每10股0.56元人民幣。

九源基因(02566)將於7月30日派發末期股息每10股0.56元

九源基因：2024年收益達人民幣1,369.2百萬元，同比增長6.4%

九源基因04月09日主力淨流入35萬元散户資金拋售

九源基因04月07日遭主力拋售110萬元

九源基因完成名稱更改登記手續新名稱正式生效

九源基因(02566)完成名稱更改登記手續新名稱正式生效

智通财经网

九源基因：2024年公司營業收入同比增長6.4%，毛利率提升至79%

九源基因03月28日主力淨流出23萬元散户資金買入

九源基因去年淨利增超15%，減重版司美格魯肽或明年上半年提交上市申請

九源基因2024年營收13.69億元：“司美”首個仿製藥申報者，押寶“網紅”賽道尋新增長

21世纪经济报道

九源基因發佈上市後首份業績公告！2024年實現營收13.69億元骨科產品複合增長率超33%

智通财经网

首款國產司美格魯肽要來了？九源基因在財報中預計下半年獲批

九源基因(02566)發佈年度業績股東應佔溢利1.39億元同比增加15.72% 擬派發末期股息每10股0.56元

未來兩個月“基石投資者”解禁名單出爐！九源基因已浮虧1.19億！

九源基因03月20日主力淨流出17萬元散户資金買入

金十數據整理：每日港股市場要聞速遞（3月17日週一）

九源基因(02566.HK)將於3月26日舉行董事會會議以審批2024年全年業績以及考慮建議派發末期股息（如有）。

九源基因03月14日主力淨流入82萬元散戶資金拋售

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02566/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02566","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02566\",,,,,undefined,":{"symbol":"02566","market":"HK","secType":"STK","nameCN":"九源基因","latestPrice":6.09,"timestamp":1746778087016,"preClose":6.09,"halted":0,"volume":55400,"delay":0,"floatShares":109000000,"shares":245000000,"eps":0.7293466708020907,"marketStatus":"已收盤","change":0,"latestTime":"05-09 16:08:07","open":6.09,"high":6.1,"low":6.04,"amount":337102,"amplitude":0.009852,"askPrice":6.09,"askSize":59000,"bidPrice":6.02,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":0.7293466708020907,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1747013400000},"marketStatusCode":5,"adr":0,"listingDate":1732723200000,"exchange":"SEHK","adjPreClose":6.09,"dividendRate":0.009788,"openAndCloseTimeList":[[1746754200000,1746763200000],[1746766800000,1746777600000]],"volumeRatio":0.957815,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02566\",,,,,undefined,":{"symbol":"02566","floatShares":109000000,"roa":"6.08%","roe":"11.47%","lyrEps":0.729347,"volumeRatio":0.957815,"shares":245000000,"dividePrice":0.060183,"high":6.1,"amplitude":0.009852,"preClose":6.09,"low":6.04,"week52Low":5.18,"pbRate":"0.91","psRate":"1.01","week52High":9.1,"institutionHeld":0,"latestPrice":6.09,"committee":-0.966667,"eps":0.7293466708020907,"divideRate":0.009788,"volume":55400,"delay":0,"ttmEps":0.7293466708020907,"open":6.09,"prevYearClose":6.6,"prevWeekClose":5.98,"prevMonthClose":5.95,"prevQuarterClose":6.78,"fiveDayClose":5.95,"twentyDayClose":5.59,"sixtyDayClose":6.3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02566\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2531216765","title":"九源基因：2024年腫瘤產品佔營收19.47%，血液產品佔9.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531216765","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531216765?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 09:25","pubTimestamp":1745889900,"startTime":"0","endTime":"0","summary":"来源：Gangtise投研九源基因（02566.HK）2024年度业绩发布会：九源基因成立于1993年，专注生物医药领域，拥有9款商业化产品，涵盖肿瘤、骨科、血液和代谢四大领域。2024年肿瘤产品占营收19.47%，血液产品占9.96%。其骨科重点产品为国内首款含RHBNP蛋白的骨复合材料，适用于多种骨修复场景。公司正布局院内和院外市场，尤其注重线上互联网药店合作，已与近岸蛋白签署合作协议，共同开发透明质酸酶平台，旨在提升药物渗透分散性，实现给药方式创新。责任编辑：王若云","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429092636a6cc6f5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429092636a6cc6f5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2529648030","title":"【九源基因(02566.HK)將於7月30日派發末期股息每10股0.56元】九源基因(02566.HK)發佈公告，該公司將於2025年7月30日派發末期股息每10股0.56元人民幣。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529648030","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529648030?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 12:23","pubTimestamp":1745468623,"startTime":"0","endTime":"0","summary":"九源基因(02566.HK)发布公告，该公司将于2025年7月30日派发末期股息每10股0.56元人民币。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/24122349819418.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02566"],"gpt_icon":0},{"id":"2529486816","title":"九源基因(02566)將於7月30日派發末期股息每10股0.56元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529486816","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529486816?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 12:20","pubTimestamp":1745468433,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九源基因(02566)发布公告，该公司将于2025年7月30日派发末期股息每10股0.56元人民币。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1283820.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02566"],"gpt_icon":0},{"id":"2529364877","title":"九源基因：2024年收益達人民幣1,369.2百萬元，同比增長6.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529364877","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529364877?lang=zh_tw&edition=fundamental","pubTime":"2025-04-24 12:13","pubTimestamp":1745467984,"startTime":"0","endTime":"0","summary":"金融界4月24日消息，九源基因公布2024年年报，期内收益为人民币1,369.2百万元，同比增长6.4%；母公司股东应占年内溢利为人民币138.6百万元；每股基本盈利为人民币0.68元。以上数据未经审核。\n\n\r\n            责任编辑：栎树","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/24121349819071.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02566"],"gpt_icon":0},{"id":"2526333230","title":"九源基因04月09日主力淨流入35萬元 散户資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2526333230","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526333230?lang=zh_tw&edition=fundamental","pubTime":"2025-04-09 16:16","pubTimestamp":1744186609,"startTime":"0","endTime":"0","summary":"04月09日, 九源基因股价涨1.04%，报收5.84元，成交金额101万元，换手率0.17%，振幅8.30%，量比0.67。九源基因今日主力资金净流入35万元，上一交易日主力净流出0万元。该股近5个交易日下跌12.84%，主力资金累计净流出95万元；近20日主力资金累计净流出153万元，其中净流出天数为5日。该股主力净额占比0.06%，港股市场排名159/2652。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409171009a6b53a7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409171009a6b53a7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2525609463","title":"九源基因04月07日遭主力拋售110萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525609463","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525609463?lang=zh_tw&edition=fundamental","pubTime":"2025-04-07 16:16","pubTimestamp":1744013784,"startTime":"0","endTime":"0","summary":"04月07日, 九源基因股价跌14.26%，报收5.59元，成交金额464万元，换手率0.74%，振幅10.43%，量比5.06。九源基因今日主力资金净流出110万元，上一交易日主力净流出20万元。该股近5个交易日下跌20.93%，主力资金累计净流出130万元；近20日主力资金累计净流出116万元，其中净流出天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407170716a6b26ea0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407170716a6b26ea0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2524464157","title":"九源基因完成名稱更改登記手續 新名稱正式生效","url":"https://stock-news.laohu8.com/highlight/detail?id=2524464157","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524464157?lang=zh_tw&edition=fundamental","pubTime":"2025-04-02 17:26","pubTimestamp":1743585999,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九源基因(02566)发布公告，继公司股东通过特别决议案批准更改公司名称后，截至本公告日期，公司已就更改公司名称向中国相关政府机关完成登记手续，并已取得换发的营业执照。因此，更改公司名称自本公告日期起生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040219110794c9b7c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040219110794c9b7c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2524245764","title":"九源基因(02566)完成名稱更改登記手續 新名稱正式生效","url":"https://stock-news.laohu8.com/highlight/detail?id=2524245764","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524245764?lang=zh_tw&edition=fundamental","pubTime":"2025-04-02 17:26","pubTimestamp":1743585960,"startTime":"0","endTime":"0","summary":"九源基因(02566)发布公告，继公司股东通过特别决议案批准更改公司名称后，截至本公告日期，公司已就更改公司名称向中国相关政府机关完成登记手续，并已取得换发的营业执照。因此，更改公司名称自本公告日期起生效。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-04-02/doc-inerupah5254491.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02566"],"gpt_icon":0},{"id":"2523932250","title":"九源基因：2024年公司營業收入同比增長6.4%，毛利率提升至79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2523932250","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523932250?lang=zh_tw&edition=fundamental","pubTime":"2025-03-31 09:29","pubTimestamp":1743384540,"startTime":"0","endTime":"0","summary":"　　九源基因2024年度业绩发布会：九源基因2024年度业绩发布会介绍了公司经营亮点与未来规划。公司营业收入达13.69亿人民币，同比增长6.4%，毛利率提升至79%，核心产品保持高增速，生物药近3~4年平均增幅21.7%。公司2024年上市，引入多家战略投资人，公众认购倍数超670倍。研发方面，2024年JY06获上市批准，JY54等多款在研产品聚焦骨科、代谢等领域，未来有望推出多款新品。未来公司将持续拓展业务，提升市场份额，预计2025年营收增速达10%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-03-31/doc-inerpcsu7347851.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02566"],"gpt_icon":0},{"id":"2522547686","title":"九源基因03月28日主力淨流出23萬元 散户資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2522547686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522547686?lang=zh_tw&edition=fundamental","pubTime":"2025-03-28 16:16","pubTimestamp":1743149773,"startTime":"0","endTime":"0","summary":"03月28日, 九源基因股价跌1.26%，报收7.07元，成交金额86万元，换手率0.11%，振幅3.63%，量比0.93。九源基因今日主力资金（超大单+大单）净流出23万元，上一交易日主力净流出0万元。该股近5个交易日上涨2.47%，主力资金累计净流出23万元；近20日主力资金累计净流入64万元，其中净流入天数为3日。该股主力净额占比0.03%（主力资金净额/流通市值），港股市场排名2469/2650。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250328165457a6a73347&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250328165457a6a73347&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2522302862","title":"九源基因去年淨利增超15%，減重版司美格魯肽或明年上半年提交上市申請","url":"https://stock-news.laohu8.com/highlight/detail?id=2522302862","media":"澎湃新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522302862?lang=zh_tw&edition=fundamental","pubTime":"2025-03-27 22:14","pubTimestamp":1743084840,"startTime":"0","endTime":"0","summary":"手握司美格鲁肽生物类似药的九源基因公布港股上市后首份业绩公告。九源基因司美格鲁肽JY29-2治疗糖尿病适应证于2024年4月国内第一家申报生产文号，治疗肥胖和超重适应证进入三期临床，并完成全部病例入组。在3月27日的业绩交流会上，九源基因相关负责人提到，减重适应证2026年上半年报产。预计2025年内向巴西、沙特递交司美格鲁肽的新药申请。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2025-03-27/doc-inerceuh0520899.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-03-27/doc-inerceuh0520899.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02566"],"gpt_icon":0},{"id":"2522317409","title":"九源基因2024年營收13.69億元：“司美”首個仿製藥申報者，押寶“網紅”賽道尋新增長","url":"https://stock-news.laohu8.com/highlight/detail?id=2522317409","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522317409?lang=zh_tw&edition=fundamental","pubTime":"2025-03-27 14:55","pubTimestamp":1743058500,"startTime":"0","endTime":"0","summary":"3月26日，九源基因发布的业绩公告显示，该公司2024年实现总收入13.69亿元，同比增长6.4%；净利润1.386亿元，同比增长15.7%。九源基因的招股书数据显示，公司在2021年、2022年、2023年的营收分别为13.07亿元、11.25亿元、12.87亿元，净利润分别为1.19亿元、5986.7万元、1.20亿元。近两年，九源基因因成为“国内首个司美格鲁肽仿制药申报者”而备受瞩目。九源基因迅速抓住申报的先机，一时成为资本市场关注的焦点。面对困境，九源基因必须寻找新的突破口。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250327150315a4439716&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250327150315a4439716&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2522813366","title":"九源基因發佈上市後首份業績公告！2024年實現營收13.69億元 骨科產品複合增長率超33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2522813366","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522813366?lang=zh_tw&edition=fundamental","pubTime":"2025-03-27 08:25","pubTimestamp":1743035138,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，3月26日，九源基因公布了上市后首份年度业绩公告，公司2024年实现总收入13.69亿元，同比增长6.4%;净利润1.386亿元，同比增长15.7%。核心产品营收稳健增长 持续耕耘研发创新加速产品线拓展财报显示，2024年，九源基因继续深耕骨科、代谢、肿瘤及血液四大治疗领域，实现全面突破，全年营业收入达13.69亿元，同比增长6.4%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025032708320694c21c7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025032708320694c21c7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2522848943","title":"首款國產司美格魯肽要來了？九源基因在財報中預計下半年獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=2522848943","media":"第一财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522848943?lang=zh_tw&edition=fundamental","pubTime":"2025-03-26 21:51","pubTimestamp":1742997060,"startTime":"0","endTime":"0","summary":"2024年4月，九源基因在国内提交了司美格鲁肽治疗二型糖尿病的上市申请，在国内诸多款司美格鲁肽生物类似药中拔得了头筹。诺和诺德的司美格鲁肽专利面临到期，如在中国市场，专利到期日是在2026年3月20日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-03-26/doc-ineqyzvi8756172.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-03-26/doc-ineqyzvi8756172.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02566"],"gpt_icon":0},{"id":"2522437803","title":"九源基因(02566)發佈年度業績 股東應佔溢利1.39億元 同比增加15.72% 擬派發末期股息每10股0.56元","url":"https://stock-news.laohu8.com/highlight/detail?id=2522437803","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522437803?lang=zh_tw&edition=fundamental","pubTime":"2025-03-26 20:53","pubTimestamp":1742993616,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九源基因 发布截至2024年12月31日止年度业绩，该集团期内取得收益13.69亿元，同比增加6.4%;公司拥有人应占溢利1.39亿元，同比增加15.72%;每股基本盈利0.68元;拟派发末期股息每10股0.56元。销售货品的收益由截至2023年12月31日止年度的12.19亿元增加6.6%至截至2024年12月31日止年度的12.99亿元，这与骨优导的销售收益的增长一致。集团的毛利由截至2023年12月31日止年度的9.91亿元增加9.2%至截至2024年12月31日止年度的10.82亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1268340.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02566"],"gpt_icon":0},{"id":"2520439966","title":"未來兩個月“基石投資者”解禁名單出爐！九源基因已浮虧1.19億！","url":"https://stock-news.laohu8.com/highlight/detail?id=2520439966","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520439966?lang=zh_tw&edition=fundamental","pubTime":"2025-03-20 17:52","pubTimestamp":1742464320,"startTime":"0","endTime":"0","summary":"　　据LiveReport大数据统计，四至五月份共计11家公司的基石解禁，其中四月份有4家，5月份有7家；距离解禁日最近的公司为卡罗特，13天后基石将解禁5418.30万股，占解禁后流通股股本的35.32%。　　据LiveReport大数据，截至3月20日11家公司的基石中有4家浮亏，分别为卡罗特、华昊中天医药-B、傲基股份及九源基因，分别浮亏金额约为433.46万、8231.32万、2932.86万及1.19亿港元，截至当前，基石浮亏最大的公司为九源基因。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-03-20/doc-ineqiarh4712746.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02566"],"gpt_icon":0},{"id":"2520438706","title":"九源基因03月20日主力淨流出17萬元 散户資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2520438706","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520438706?lang=zh_tw&edition=fundamental","pubTime":"2025-03-20 16:16","pubTimestamp":1742458596,"startTime":"0","endTime":"0","summary":"03月20日, 九源基因股价跌0.83%，报收7.16元，成交金额156万元，换手率0.20%，振幅1.39%，量比0.55。九源基因今日主力资金净流出17万元，上一交易日主力净流出0万元。该股近5个交易日上涨5.60%，主力资金累计净流入65万元；近20日主力资金累计净流入95万元，其中净流入天数为6日。该股主力净额占比0.02%，港股市场排名2378/2651。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250320165603a43b0dcc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250320165603a43b0dcc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0},{"id":"2520539405","title":"金十數據整理：每日港股市場要聞速遞（3月17日 週一）","url":"https://stock-news.laohu8.com/highlight/detail?id=2520539405","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520539405?lang=zh_tw&edition=fundamental","pubTime":"2025-03-17 09:04","pubTimestamp":1742173478,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1592","IE0008368742.USD","02015","BK1136","LU2148510915.USD","LU0405327148.USD","BK1542","BK1229","YANG","BK0012","BK0224","LU0396098781.USD","IE00B5MMRT66.SGD","LU2213484517.USD","LU2495084118.USD","IE0031814852.USD","EVS.SI","LU0593848301.USD","02555","02777","LU2097828557.USD","BK0028","07226","LU1366334578.USD","02566","BK1240","IE00B543WZ88.USD","601099","LI","03377","LU0405327494.USD","HSCEI","HSTECH","BK0188","SGXZ49509284.SGD","BK1588","000333","06098","LU2778985437.USD","02601","LU2097828631.EUR","BK0207","LU0287142896.SGD","601601","01378","00300","BK1575","BK1594","BK0201","IE00B031HY20.USD"],"gpt_icon":0},{"id":"2519874020","title":"九源基因(02566.HK)將於3月26日舉行董事會會議以審批2024年全年業績以及考慮建議派發末期股息（如有）。","url":"https://stock-news.laohu8.com/highlight/detail?id=2519874020","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519874020?lang=zh_tw&edition=fundamental","pubTime":"2025-03-14 18:50","pubTimestamp":1741949438,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["02566"],"gpt_icon":0},{"id":"2519087399","title":"九源基因03月14日主力淨流入82萬元 散戶資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2519087399","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519087399?lang=zh_tw&edition=fundamental","pubTime":"2025-03-14 16:15","pubTimestamp":1741940150,"startTime":"0","endTime":"0","summary":"03月14日, 九源基因股价涨7.23%，报收7.27元，成交金额903万元，换手率1.13%，振幅9.59%，量比7.02。九源基因今日主力资金净流入82万元，上一交易日主力净流出102万元。该股近5个交易日上涨6.91%，主力资金累计净流入53万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入155万元，其中净流入天数为9日。该股主力净额占比0.10%，港股市场排名119/2653。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250314164939ab653dce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250314164939ab653dce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02566"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":94,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02566\",params:#limit:5,,,undefined,":[{"date":"2025-06-13","symbol":"02566","amount":0.056,"announcedDate":"2025-03-26","type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2025-06-16","defaultRemindTime":1749778200000,"name":"九源基因","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-30","payableDate":"2025-06-16","currency":"CNY","dateTimestamp":1749744000000,"payDate":"2025-07-30"},{"date":"2025-03-26","symbol":"02566","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742952600000,"name":null,"time":"","dateTimestamp":1742918400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02566\",market:\"HK\",,,undefined,":[{"executeDate":"2025-06-13","recordDate":"2025-06-16","paymentDate":"2025-07-30","value":0.056,"currency":"CNY"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02566\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02566\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02566","date":"2025-05-08","current":10.406872,"percent":0.352941,"low":9.307514,"twenty":10.058598,"median":11.208381,"eighty":12.478117,"high":14.699674,"avg":11.385796,"sd":1.310589,"marketCap":1494478692},"quantilePoints":[{"date":"2024-12-06","current":14.097915,"twenty":14.208262,"median":14.275695,"eighty":14.595644,"marketCap":1946012484},{"date":"2024-12-13","current":13.217326,"twenty":13.348436,"median":13.95821,"eighty":14.334483,"marketCap":1820859096},{"date":"2024-12-20","current":12.20261,"twenty":12.40882,"median":13.381214,"eighty":14.243818,"marketCap":1673619816},{"date":"2024-12-27","current":12.158366,"twenty":12.254449,"median":13.1954,"eighty":14.180675,"marketCap":1666257852},{"date":"2025-01-03","current":11.126814,"twenty":12.0799,"median":12.46117,"eighty":14.042033,"marketCap":1526380536},{"date":"2025-01-10","current":9.714633,"twenty":11.141125,"median":12.29741,"eighty":13.763077,"marketCap":1327607508},{"date":"2025-01-17","current":9.904165,"twenty":10.518129,"median":12.180488,"eighty":13.509332,"marketCap":1354601376},{"date":"2025-01-24","current":10.07429,"twenty":9.9409,"median":12.04207,"eighty":13.348436,"marketCap":1386503220},{"date":"2025-01-28","current":10.358786,"twenty":9.995541,"median":11.819979,"eighty":13.282881,"marketCap":1433128992},{"date":"2025-02-07","current":11.238302,"twenty":10.0243,"median":11.162591,"eighty":13.191014,"marketCap":1546012440},{"date":"2025-02-14","current":11.154484,"twenty":10.062805,"median":11.126814,"eighty":12.776093,"marketCap":1533742500},{"date":"2025-02-21","current":12.73316,"twenty":10.073062,"median":11.193598,"eighty":12.735779,"marketCap":1757055408},{"date":"2025-02-28","current":11.508443,"twenty":10.189099,"median":11.508443,"eighty":12.653552,"marketCap":1582822260},{"date":"2025-03-07","current":12.084413,"twenty":10.276651,"median":11.554796,"eighty":12.584056,"marketCap":1668711840},{"date":"2025-03-14","current":12.91496,"twenty":10.28916,"median":11.611229,"eighty":12.584056,"marketCap":1784049276},{"date":"2025-03-21","current":12.244709,"twenty":10.311241,"median":11.810026,"eighty":12.735779,"marketCap":1690797732},{"date":"2025-03-28","current":11.696332,"twenty":10.344738,"median":11.831112,"eighty":12.72799,"marketCap":1734969516},{"date":"2025-04-03","current":10.807781,"twenty":10.395616,"median":11.800074,"eighty":12.674918,"marketCap":1600000176},{"date":"2025-04-11","current":9.828764,"twenty":10.27298,"median":11.65378,"eighty":12.589531,"marketCap":1445398932},{"date":"2025-04-17","current":9.988361,"twenty":10.075173,"median":11.569961,"eighty":12.56072,"marketCap":1472392800},{"date":"2025-04-25","current":10.079541,"twenty":10.050182,"median":11.463659,"eighty":12.511173,"marketCap":1487116728},{"date":"2025-05-02","current":10.290636,"twenty":10.067013,"median":11.287756,"eighty":12.494061,"marketCap":1467484824},{"date":"2025-05-08","current":10.406872,"twenty":10.058598,"median":11.208381,"eighty":12.478117,"marketCap":1494478692}],"updateTime":1746803884652}}}